A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients - Related Studies

A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients

This study has been completed.

Study NCT00002000. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Herpes Simplex
		HIV Infections

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		Communicable Diseases
		Herpesviridae Infections
		Infection

3	More general conditions related to this trial
		DNA Virus Infections
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Skin Diseases
		Skin Diseases, Infectious
		Skin Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		Valacyclovir hydrochloride
		Acyclovir

5	Additional drug interventions recognized in this trial
		Valacyclovir

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Antiviral Agents
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		Glaxo Wellcome